All In Biotech

Drug Trial Radar · NCT06977581

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RANGING STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF-07275315 IN ADULT PARTICIPANTS WITH INADEQUATELY CONTROLLED MODERATE-TO-SEVERE ASTHMA

Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 252 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

252

Planned (sponsor's estimate)

Start

May 20, 2025

Primary completion

Mar 8, 2027

Study completion May 31, 2027

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
May 18, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning of people who are affected. This study is seeking participants who: * Are 18 to 75 years old * Have had moderate-to-severe asthma for at least 12 months that is not well controlled * Have been taking their regular maintenance treatment(s) for asthma over the last 6 months All participants will receive PF-07275315 or a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. PF-07275315 or placebo will be given as multiple shots in the clinic over the course of 12 weeks. We will compare the experiences of people receiving PF-07275315 to those of the people who do not. This will help us determine if PF-07275315 is safe and effective. Participants will be involved in this study for up to approximately 9.5 months depending on local requirements.

Conditions

  • Asthma

Interventions

  • PF-07275315Drug

    subcutaneous injection

  • PlaceboOther

    subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in pre-bronchodilator Forced Expiratory Volume in 1 Second (FEV1) at Week 12Time frame: Week 12
  2. Treatment-Emergent Adverse Events (AEs), Serious AEs (SAEs), and AEs/SAEs leading to treatment discontinuationTime frame: Baseline through Week 24
  3. Clinically significant, treatment-related laboratory abnormalitiesTime frame: Baseline through Week 24
  4. Clinically significant, treatment-related abnormalities in vital signsTime frame: Baseline through Week 24
  5. Clinically significant, treatment-related electrocardiogram (ECG) abnormalitiesTime frame: Baseline through Week 24

Locations

137 sites in 15 countries. Site status is shown where the registry gives one.

  • Velocity Clinical Research, Mobile

    Mobile, Alabama · Recruiting

  • Chandler Clinical Trials

    Chandler, Arizona · Recruiting

  • Antelope Valley Clinical Trials

    Lancaster, California · Recruiting

  • NewportNativeMD, Inc.

    Newport Beach, California · Recruiting

  • California Medical Research Associates

    Northridge, California · Recruiting

  • Allergy and Asthma Associates of Santa Clara Valley Research Center

    San Jose, California · Recruiting

  • Allergy & Asthma Clinical Research

    Walnut Creek, California · Recruiting

  • Colorado ENT & Allergy

    Colorado Springs, Colorado · Recruiting

  • Cpcc-Research Llc

    East Point, Georgia · Recruiting

  • Christie Clinic - University

    Champaign, Illinois · Recruiting

  • Innovo Research - Christie Clinic

    Champaign, Illinois · Recruiting

  • Christie Clinic - Windsor

    Champaign, Illinois · Recruiting

  • University of Kansas Medical Center

    Kansas City, Kansas · Recruiting

  • North Ingalls Building

    Ann Arbor, Michigan · Recruiting

  • University of Michigan

    Ann Arbor, Michigan · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • Henderson Clinical Trials

    Henderson, Nevada · Recruiting

  • Rutgers, Robert Wood Johnson Medical School

    New Brunswick, New Jersey · Recruiting

  • Circuit Clinical / Impact Medical Allergy, Asthma & Immunology

    Riverdale, New Jersey · Recruiting

  • American Health Research

    Charlotte, North Carolina · Recruiting

  • Clinical Research Of Gastonia

    Gastonia, North Carolina · Recruiting

  • Stern Research Partners, LLC

    Huntersville, North Carolina · Recruiting

  • Toledo Institute of Clinical Research Inc.

    Toledo, Ohio · Recruiting

  • OK Clinical Research

    Edmond, Oklahoma · Recruiting

  • Allergy, Asthma and Clinical Research

    Oklahoma City, Oklahoma · Recruiting

  • Layrek Clinical Research

    Tulsa, Oklahoma · Recruiting

  • Clinical Research Associates of Central PA, LLC

    DuBois, Pennsylvania · Recruiting

  • Clinical Research of Rock Hill

    Rock Hill, South Carolina · Recruiting

  • Premier Research Center, LLC

    Hendersonville, Tennessee · Recruiting

  • South Texas Medical Research Institute, Inc., DBA TTS Research

    Boerne, Texas · Recruiting

  • Horizon Clinical Research Group

    Cypress, Texas · Recruiting

  • Alina Clinical Trials, LLC.

    Dallas, Texas · Recruiting

  • Greater Heights & Memorial Pulmonary and Sleep

    Houston, Texas · Recruiting

  • Houston Pulmonary Sleep and Allergy Associates

    Houston, Texas · Recruiting

  • Metroplex Pulmonary and Sleep Center

    McKinney, Texas · Active not recruiting

  • Clinical Research Partners, LLC

    Richmond, Virginia · Recruiting

  • Centro de Investigaciones Metabólicas (CINME)

    Buenos Aires, Argentina · Recruiting

  • Fundacion Scherbovsky

    Mendoza, Argentina · Recruiting

  • Instituto de Salud Respiratoria

    Mendoza, Argentina · Recruiting

  • Fundación Respirar

    Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina · Recruiting

Showing 40 of 137 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.